During the past decade, Rocky Mountain MS Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain MS Clinic" #1 sponsor was "John F. Foley, MD" with 4 trials, followed by "Rocky Mountain MS Research Group, LLC" with 4 trials sponsored, "Avanir Pharmaceuticals" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain MS Clinic" #1 collaborator was "Biogen" with 6 trials as a collaborator, "Abreos Biosciences" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator, "Genzyme, a Sanofi Company" with 1 trials as a collaborator and "Rho, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain MS Clinic" are "Multiple Sclerosis" (9 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Relapsing Remitting Multiple Sclerosis" (2 trials), "Central Neuropathic Pain" (1 trials) and "Clinically Isolated Syndrome" (1 trials). Many other conditions were trialed in "Rocky Mountain MS Clinic" in a lesser frequency.

Most popular intervention types in "Rocky Mountain MS Clinic" are "Drug" (4 trials), "Biological" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "13-PCV Booster" (1 trials), "23-PPV" (1 trials), "AVP-923-20" (1 trials), "AVP-923-30" (1 trials) and "AVP-923-45" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain MS Clinic" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain MS Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Rocky Mountain MS Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain MS Clinic, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".